Claudia Hagedorn
Claudia Hagedorn
University of Witten/ Herdecke
Verified email at
Cited by
Cited by
Impact of common KIBRA allele on human cognitive functions
H Wersching, K Guske, S Hasenkamp, C Hagedorn, S Schiwek, S Jansen, ...
Neuropsychopharmacology 36 (6), 1296-1304, 2011
Apolipoprotein E interrupts interleukin-1β signaling in vascular smooth muscle cells
A Kawamura, D Baitsch, R Telgmann, R Feuerborn, G Weissen-Plenz, ...
Arteriosclerosis, thrombosis, and vascular biology 27 (7), 1610-1617, 2007
Genomic cis-acting sequences improve expression and establishment of a nonviral vector
C Hagedorn, MN Antoniou, HJ Lipps
Molecular Therapy-Nucleic Acids 2, e118, 2013
Scaffold/Matrix Attached Region-Based Nonviral Episomal Vectors
C Hagedorn, SP Wong, R Harbottle, HJ Lipps
Human gene therapy 22 (8), 915-923, 2011
Molecular genetic analysis of a human insulin‐like growth factor 1 promoter P1 variation
R Telgmann, C Dördelmann, E Brand, V Nicaud, C Hagedorn, ...
The FASEB Journal 23 (5), 1303-1313, 2009
Nebivolol decreases endothelial cell stiffness via the estrogen receptor beta: a nano-imaging study
U Hillebrand, D Lang, RG Telgmann, C Hagedorn, S Reuter, K Kliche, ...
Journal of hypertension 27 (3), 517-526, 2009
S/MAR element facilitates episomal long-term persistence of adeno-associated virus vector genomes in proliferating cells
C Hagedorn, M Schnoedt-Fuchs, P Boehme, H Abdelrazik, HJ Lipps, ...
Human gene therapy 28 (12), 1169-1179, 2017
Controlled removal of a nonviral episomal vector from transfected cells
S Rupprecht, C Hagedorn, D Seruggia, T Magnusson, E Wagner, M Ogris, ...
Gene 466 (1-2), 36-42, 2010
Osteopontin gene variation and cardio/cerebrovascular disease phenotypes
K Schmidt-Petersen, E Brand, R Telgmann, V Nicaud, C Hagedorn, ...
Atherosclerosis 206 (1), 209-215, 2009
Identification and functional analyses of molecular haplotypes of the human osteoprotegerin gene promoter
C Hagedorn, R Telgmann, C Dördelmann, B Schmitz, S Hasenkamp, ...
Arteriosclerosis, thrombosis, and vascular biology 29 (10), 1638-1643, 2009
Functional and structural profiling of the human thrombopoietin gene promoter
C Dördelmann, R Telgmann, E Brand, C Hagedorn, B Schröer, ...
Journal of Biological Chemistry 283 (36), 24382-24391, 2008
SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE Study
R Telgmann, E Brand, V Nicaud, C Hagedorn, K Beining, J Schönfelder, ...
Journal of hypertension 25 (3), 557-564, 2007
Capsid engineering of adenovirus vectors: overcoming early vector–host interactions for therapy
C Hagedorn, F Kreppel
Human gene therapy 28 (10), 820-832, 2017
Viral hybrid-vectors for delivery of autonomous replicons
W Zhang, C Hagedorn, E Schulz, HJ Lipps, A Ehrhardt
Current gene therapy 14 (1), 10-23, 2014
Characterization and functional analyses of the human G protein–coupled receptor kinase 4 gene promoter
S Hasenkamp, R Telgmann, JA Staessen, C Hagedorn, C Dördelmann, ...
Hypertension 52 (4), 737-746, 2008
A colony-forming assay for determining the establishment efficiency of S/MAR-containing nonviral episomal expression vectors
C Hagedorn, A Baiker, J Postberg, A Ehrhardt, HJ Lipps
Cold Spring Harbor protocols 2012 (6), pdb. prot069500, 2012
Handling S/MAR Vectors
C Hagedorn, A Baiker, J Postberg, A Ehrhardt, HJ Lipps
Cold Spring Harbor Protocols 2012 (6), pdb. top068262, 2012
Circadian hepatocyte clocks keep synchrony in the absence of a master pacemaker in the suprachiasmatic nucleus or other extrahepatic clocks
F Sinturel, P Gos, V Petrenko, C Hagedorn, F Kreppel, KF Storch, D Knutti, ...
Genes & development 35 (5-6), 329-334, 2021
Role of genetic variants in autecological research
C Hagedorn
Microbial autecology: a method for environmental studies., 61-74, 1986
pEPI for gene therapy non viral episomes and their application in somatic gene therapy
C Hagedorn, HJ Lipps
J Cell Sci Ther S 6, 2, 2011
The system can't perform the operation now. Try again later.
Articles 1–20